A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's Disease
- 28 September 1989
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 321 (13), 845-850
- https://doi.org/10.1056/nejm198909283211301
Abstract
We randomly assigned 71 patients with active chronic Crohn's disease who were resistant to or intolerant of corticosteroids to treatment with oral cyclosporine (5 to 7.5 mg per kilogram of body weight per day) or placebo for three months. Disease activity was assessed on a clinical grading scale without knowledge of the treatment given.Keywords
This publication has 16 references indexed in Scilit:
- Low-dose cyclosporin for Crohn's disease: implications for clinical trialsAlimentary Pharmacology & Therapeutics, 2007
- Cyclosporin-associated nephropathy in patients with autoimmune diseasesJournal of Molecular Medicine, 1988
- Combined steroid-cyclosporin treatment of chronic autoimmune diseasesJournal of Molecular Medicine, 1987
- Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.Gut, 1985
- European Cooperative Crohn's Disease Study (ECCDS): Results of drug treatmentGastroenterology, 1984
- Azathioprine has a very limited role in the treatment of Crohn's diseaseDigestive Diseases and Sciences, 1981
- Treatment of Crohn's Disease with 6-MercaptopurineThe New England Journal of Medicine, 1980
- National Cooperative Crohn's Disease Study: Results of drug treatmentGastroenterology, 1979
- Development of a Crohn's Disease Activity IndexGastroenterology, 1976
- Tables of Critical Values for the Pratt Matched Pair Signed Rank StatisticJournal of the American Statistical Association, 1974